UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Breast cancer research : BCR, 2023-10, Vol.25 (1), p.112-112, Article 112

2023

Link zum Volltext

Verfügbarkeit prüfen

Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4020-4028

2021

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in no‐show rates for screening mammography

Cancer, 2021-06, Vol.127 (11), p.1857-1863

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine, 2022-12, Vol.86, p.104316-104316, Article 104316

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women

Cancer prevention research (Philadelphia, Pa.), 2015-10, Vol.8 (10), p.912-921

2015

Link zum Volltext

Verfügbarkeit prüfen

Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis

JCO precision oncology, 2023-05, Vol.7, p.e2200531

2023

Link zum Volltext

Verfügbarkeit prüfen

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women

Cancer prevention research (Philadelphia, Pa.), 2015-10, Vol.8 (10), p.922-931

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-10-14: Racial differences in no-show rate for screening mammogram

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-10-14

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported reasons for no-shows to screening mammogram appointments among African American women

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18534-e18534

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-10-02: Random periareolar fine-needle aspiration (RPFNA) cell number, prior precancerous breast disease and subsequent uptake of a prevention intervention predict short-term breast cancer risk

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-10-02

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-07-02: Genomic predictors of rapid progression to first line endocrine and CDK4/6 inhibitor combination therapy in patients with estrogen receptor positive (ER+) HER-2 negative (HER2-) advanced breast cancer (ABC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-07-02

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of TP53 mutation status in metastatic triple-negative and hormone receptor-positive breast cancer using cell-free DNA genomic profiling

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13099-e13099

2023

Link zum Volltext

Verfügbarkeit prüfen

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer analysis

Breast cancer research : BCR, 2023-10, Vol.25 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-23-10: Gene expression and mutation profiles in HER2-mutated metastatic breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-23-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Defining resistance mechanisms to CDK4/6 inhibition in hormone receptor-positive HER2-negative metastatic breast cancer (MBC) through a machine learning approach applied to circulating tumor DNA (ctDNA)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3055-3055

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-01-01: Genetic alterations detected by circulating tumor DNA (ctDNA) in HER2-low metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-01-01

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD6-08: Exploring the interplay among ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD6-08-PD6-08

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD14-04: Circulating tumor DNA characterization of invasive lobular carcinoma in patients with metastatic breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD14-04-PD14-04

2022

Link zum Volltext

Verfügbarkeit prüfen

Uncovering the differential impact of ESR1 and PIK3CA codon variants on the clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1033-1033

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6744: Cell-free DNA detection of alterations in the MAPK pathway in metastatic hormone receptor positive breast cancer: A multi-institutional analysis of incidence and clinical outcomes

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6744-6744

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-05-08: Prevalence and prognosis of ER-loss in advanced invasive lobular carcinoma

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-05-08

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD13-09: PD13-09 Clinical outcomes of patients with HR+ HER2- advanced breast cancer with early progression on CDK4/6 inhibitors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD13-09-PD13-09

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD10-01: PD10-01 Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD10-01-PD10-01

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-02-07: Cell-free DNA detection of GATA3 mutations in metastatic hormone receptor positive breast cancer: a retrospective, observational multi-institutional analysis

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-02-07

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Female
(8)
Humans
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Oncology
(7)
Breast Cancer
(4)
Breast Neoplasms - Genetics
(4)
Adult
(3)
Breast Neoplasms - Drug Therapy
(3)
Genomics
(3)
Middle Aged
(3)
Retrospective Studies
(3)
Aged
(2)
Biomarkers, Tumor - Blood
(2)
Breast Neoplasms - Blood
(2)
Breast Neoplasms - Pathology
(2)
Breast Neoplasms - Prevention & Control
(2)
Chromatography, Thin Layer
(2)
Circulating Tumor Dna - Genetics
(2)
Circulating Tumour Dna
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(25)
Publisher website
(19)
MEDLINE
(8)
Journals@Ovid Full Text
(7)
Ingenta
(7)
IngentaConnect Journals
(6)
Nexis
(2)
SpringerLink
(2)
Wiley Online Library
(1)
Wiley Online Library
(1)
SpringerLink Series
(1)
Elsevier ScienceDirect Journals Complete
(1)

7 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists

Racial differences in no‐show rates for screening mammography

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women

Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women

Abstract P2-10-14: Racial differences in no-show rate for screening mammogram

Patient-reported reasons for no-shows to screening mammogram appointments among African American women

Abstract P2-10-02: Random periareolar fine-needle aspiration (RPFNA) cell number, prior precancerous breast disease and subsequent uptake of a prevention intervention predict short-term breast cancer risk

Abstract P2-07-02: Genomic predictors of rapid progression to first line endocrine and CDK4/6 inhibitor combination therapy in patients with estrogen receptor positive (ER+) HER-2 negative (HER2-) advanced breast cancer (ABC)

Prognostic value of TP53 mutation status in metastatic triple-negative and hormone receptor-positive breast cancer using cell-free DNA genomic profiling

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer analysis

Abstract P2-23-10: Gene expression and mutation profiles in HER2-mutated metastatic breast cancer

Defining resistance mechanisms to CDK4/6 inhibition in hormone receptor-positive HER2-negative metastatic breast cancer (MBC) through a machine learning approach applied to circulating tumor DNA (ctDNA)

Abstract P2-01-01: Genetic alterations detected by circulating tumor DNA (ctDNA) in HER2-low metastatic breast cancer (MBC)

Abstract PD6-08: Exploring the interplay among ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS)

Abstract PD14-04: Circulating tumor DNA characterization of invasive lobular carcinoma in patients with metastatic breast cancer

Uncovering the differential impact of ESR1 and PIK3CA codon variants on the clinical phenotype of metastatic breast cancer (MBC) through circulating tumor DNA (ctDNA) next-generation sequencing (NGS)

Abstract 6744: Cell-free DNA detection of alterations in the MAPK pathway in metastatic hormone receptor positive breast cancer: A multi-institutional analysis of incidence and clinical outcomes

Abstract P3-05-08: Prevalence and prognosis of ER-loss in advanced invasive lobular carcinoma

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerResearch in context

Abstract PD13-09: PD13-09 Clinical outcomes of patients with HR+ HER2- advanced breast cancer with early progression on CDK4/6 inhibitors

Abstract PD10-01: PD10-01 Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach

Abstract P5-02-07: Cell-free DNA detection of GATA3 mutations in metastatic hormone receptor positive breast cancer: a retrospective, observational multi-institutional analysis

Suchergebnisse filtern